- Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory?
-
Imterat M, Harter P
- KMID: 2526125
- J Gynecol Oncol.
- 2021 Jul;32(4):e61.
- doi: 10.3802/jgo.2021.32.e61
-
- CITED
-
- Close
- SHARE
-
- Close
- Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
-
Bujnak AC, Tewari KS
- KMID: 2526126
- J Gynecol Oncol.
- 2021 Jul;32(4):e62.
- doi: 10.3802/jgo.2021.32.e62
-
- CITED
-
- Close
- SHARE
-
- Close
- Report from the 36th Annual Meeting of the Korean Society of Gynecologic Oncology (KSGO)
-
Kim JH, Noh JJ, Eoh KJ, Kim YT
- KMID: 2526130
- J Gynecol Oncol.
- 2021 Jul;32(4):e75.
- doi: 10.3802/jgo.2021.32.e75
-
- CITED
-
- Close
- SHARE
-
- Close
- Towards the elimination of cervical cancer in Japan
-
Hanley SJ
- KMID: 2526131
- J Gynecol Oncol.
- 2021 Jul;32(4):e76.
- doi: 10.3802/jgo.2021.32.e76
-
- CITED
-
- Close
- SHARE
-
- Close
- Major clinical research advances in gynecologic cancer in 2020
-
Lee YY, Choi MC, Park JY, Suh DH, Kim JW
- KMID: 2526123
- J Gynecol Oncol.
- 2021 Jul;32(4):e53.
- doi: 10.3802/jgo.2021.32.e53
In 2020 series, we summarized the major clinical research advances in gynecologic oncology with providing representative figures of the most influential study for 1 of each 3 gynecologic cancers: cervix,... -
- CITED
-
- Close
- SHARE
-
- Close
- How to perform sentinel node detection in high-risk endometrial cancer: one step forward
-
Balaya V, Lecuru F, Laas E
- KMID: 2526128
- J Gynecol Oncol.
- 2021 Jul;32(4):e71.
- doi: 10.3802/jgo.2021.32.e71
-
- CITED
-
- Close
- SHARE
-
- Close
- Relevance of pathologic features in risk stratification for early-stage endometrial cancer
-
Guerra E, Matias-Guiu X
- KMID: 2526127
- J Gynecol Oncol.
- 2021 Jul;32(4):e67.
- doi: 10.3802/jgo.2021.32.e67
-
- CITED
-
- Close
- SHARE
-
- Close
- Vaginal cancer as a late complication of radiotherapy for endometrial cancer and ileo-perineal fistula after total pelvic exenteration
-
Comba C, Topaktas M, Bozkurt H, Erbin A, Ozdogan B, Demir O
- KMID: 2526129
- J Gynecol Oncol.
- 2021 Jul;32(4):e63.
- doi: 10.3802/jgo.2021.32.e63
Pelvic exenteration is a highly morbid operation and remains one of the most catastrophic surgical procedures in gynecological oncology. We would like to present the case of total pelvic exenteration... -
- CITED
-
- Close
- SHARE
-
- Close
- A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial
-
Hori K, Nishio S, Ushijima K, Kasamatsu Y, Kondo E, Takehara K, Ito K
- KMID: 2526119
- J Gynecol Oncol.
- 2021 Jul;32(4):e64.
- doi: 10.3802/jgo.2021.32.e64
Objective To determine the safety and efficacy of dose-dense (dd) paclitaxel (PTX) and carboplatin (CBDCA) in treating advanced or recurrent endometrial cancer. Methods Women aged 20–75 years with histologically confirmed endometrial cancer, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial)
-
Guan J, Xue Y, Zang Ry, Liu Jh, Zhu Jq, Zheng Y, Wang B, Wang Hy, Chen Xj
- KMID: 2526124
- J Gynecol Oncol.
- 2021 Jul;32(4):e60.
- doi: 10.3802/jgo.2021.32.e60
Background Sentinel lymph node (SLN) mapping has been recommended as an alternative staging approach to lymphadenectomy for apparent uterine-confined endometrial cancer (EC). However, the prognostic value of SLN mapping alone instead... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study
-
Park JY, Lim MC, Baek MH, Park YH, Kim S
- KMID: 2526122
- J Gynecol Oncol.
- 2021 Jul;32(4):e65.
- doi: 10.3802/jgo.2021.32.e65
Objective Investigation of new drugs (INDs) is a tremendously inefficient process in terms of time and cost. Drug repositioning is another method used to investigate potential new agents in well-known drugs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer
-
Daix M, Angeles MA, Migliorelli F, Kakkos A, Gomez CM, Delbecque K, Mery E, Tock S, Gabiache E, Decuypere M, Goffin F, Martinez A, Ferron G, Kridelka F
- KMID: 2526116
- J Gynecol Oncol.
- 2021 Jul;32(4):e48.
- doi: 10.3802/jgo.2021.32.e48
Objective To evaluate the concordance between preoperative European Society for Medical Oncology (ESMO)-European Society of Gynaecological Oncology (ESGO)-European SocieTy for Radiotherapy and Oncology (ESTRO) risk classification in early-stage endometrial cancer (EC)... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro
-
Dhandapani H, Seetharaman A, Jayakumar H, Ganeshrajah S, Singh SS, Thangarajan R, Ramanathan P
- KMID: 2526121
- J Gynecol Oncol.
- 2021 Jul;32(4):e59.
- doi: 10.3802/jgo.2021.32.e59
Objective Dendritic cells (DCs) are administered as immunotherapeutic adjuvants after the completion of standard treatment in most settings. However, our Phase I trial indicated that one patient out of four, who... -
- CITED
-
- Close
- SHARE
-
- Close
- Mapping the robotic hysterectomy learning curve and re-establishing surgical training metrics
-
Turner TB, Kim KH
- KMID: 2526120
- J Gynecol Oncol.
- 2021 Jul;32(4):e58.
- doi: 10.3802/jgo.2021.32.e58
Objective Common robotic training curricula in the US entail completion of an online module followed by lab training with standardized exercises, such as manipulating needles with robotic needle drivers. Assessments are... -
- CITED
-
- Close
- SHARE
-
- Close
- Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
-
Zhou S, Xu Z, Yang B, Guan J, Shan W, Shi Y, Chen X
- KMID: 2526118
- J Gynecol Oncol.
- 2021 Jul;32(4):e57.
- doi: 10.3802/jgo.2021.32.e57
Objective This study investigated the characteristics of progestin-insensitive endometrioid endometrial cancer (EEC) and atypical endometrial hyperplasia (AEH) patients receiving fertility-sparing treatments and assessed the therapeutic effects of second-line fertility-preserving treatments. Methods Three hundred... -
- CITED
-
- Close
- SHARE
-
- Close
- Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR)
-
Angeles MA, Migliorelli F, Vidal-Sicart S, Saco A, Ordi J, Ros C, Fusté P, Munmany M, Escura S, Carreras N, Sánchez-Izquierdo N, Pahisa J, Torné A, Paredes P, Pino Md
- KMID: 2526117
- J Gynecol Oncol.
- 2021 Jul;32(4):e52.
- doi: 10.3802/jgo.2021.32.e52
Objective We aimed to evaluate the accuracy of sentinel lymph node (SLN) mapping with transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR) to detect lymph node (LN) metastases, in patients with intermediate... -
- CITED
-
- Close
- SHARE
-
- Close
